What?
My 2023 post ruined everyone’s long weekend.
Pretty sure that would mean that everyone is listening.
Also, like all my posts it was accurate.
I stand by the statement that I believe they are cutting and packaging in USA with Hemostyp made elsewhere…likely original China plant. Though UHP has never said that.
Here’s my awesome post you’re always whining about.
I have just reread it. Thank you for reminding me of its absolute genius:
Waverunners
Re: None
Friday, 05/26/2023 1:01:58 PM
I have a feeling we will soon learn that UHP has abandoned their quest to produce Hemostyp in the USA. Hence, the emphasis that now the Cutting and packaging is happening in a USA plant, not the manufacturing.
Could be wrong (doubtful) but Either way, using two facilities seems like a logistical nightmare for a company like UHP and it is my assumption that this is a huge part of why the testing has returned unsatisfactory results which they essentially admitted.
These changes wreak havoc on the original PMA and were the reasons I stated repeatedly that major amendments were needed.
Just for weekendBBQ UEEC talking points. Hot take predictions:
$2-3.50 With PMA
12+ months to PMA decision
24 months to acquisition.
In the mean time UHP May be presented a low ball offer of approximately $0.48.
This excludes potential pump and dumps.
Have a tremendous weekend. And RELAX a little.